Skip to main content

Collections

2024

Advances in Nanomedicine for Cancer Therapy
Edited by Christophe Nicot, Editor-in-Chief


2023


New Content ItemAging and Cellular Fate: Senescence, Death, or Cancer
Edited by Christophe Nicot, Editor-in-Chief


New Content ItemLatest Correspondence on Biomarkers for Cancer diagnosis, prognosis, and drug resistance
Edited by Christophe Nicot, Editor-in-Chief

Phase 2 and 3 studies
Edited by Christophe Nicot, Editor-in-Chief



2022


New Content ItemMolecular understanding and clinical aspects of immunotherapy in the treatment of cancer 
Edited by Christophe Nicot, Editor-in-Chief


2022 Liquid Biopsy TINYLiquid Biopsy at the Frontier of Early Detection, Prognosis and Cancer Treatments
Edited by Christophe Nicot, Editor-in-Chief


2022 Genome Editing TINYGenome Editing and the Future of Personalized and Targeted Cancer Medicine
Edited by Christophe Nicot, Editor-in-Chief


2021

2021 ImagemRNA therapies and mRNA vaccines in cancer
Edited by Christophe Nicot, Editor-in-Chief


2020

2020 imageNon-coding RNAs and RNA modifiers in cancer progression and cancer cells resistance to therapies
Edited by Christophe Nicot, Editor-in-Chief

2019

2019 imageMicrovesicles and Tumor Microenvironment in Cancer Development and Resistance to Therapies
Edited by Christophe Nicot, Editor-in-Chief 

2018

2018 imageOncogenic Signaling of Tyrosine Kinase in Cancer: Challenges and Therapeutic Opportunities
Edited by Christophe Nicot, Editor-in-Chief 

2017

Cancer Stem Cells
Edited by Christophe Nicot, Editor-in-Chief

2016

miRNA regulation in cancer
Edited by Christophe Nicot, Editor-in-Chief 

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 27.7
    5-year Journal Impact Factor: 31.3
    Source Normalized Impact per Paper (SNIP): 4.737
    SCImago Journal Rank (SJR): 8.222

    Speed 2023
    Submission to first editorial decision (median days): 3
    Submission to acceptance (median days): 91

    Usage 2023
    Downloads: 3,569,666
    Altmetric mentions: 2,070